NURSl 5434/l NURS5434l CAD/Lipidsl Quizl
(NEWl 2026l Update)l –l Familyl IIIl (FNPl
3)l Guidel |l Questionsl &l Answersl |l Gradel
A|l 100%l Correctl (Verifiedl Solutions)-l
UTA
QUESTION
Describel thel possiblel usel ofl coronaryl arteryl calciuml (CAC)l scoringl inl 2018l guidelines.
Answer:
Usefull when:
-l Patientl isl reluctantl tol takel al statin
-l Patientl isl hesitantl tol restartl statinl therapy
-l Menl 55-80,l Womenl 60-80l withl lowl riskl factorsl andl questionl thel benefitsl of
statinl therapy
-l Adultsl 40-55yrsl withl al 10yrl ASCVDl Calculatedl Riskl ofl 5-7.5%l thatl alsol havel risk
enhancers
-l Strongl relationl betweenl CACl Scorel andl riskl ofl MI
QUESTION
Whatl isl al CACl CT?
Answer:
-l Itl isl al CTl withl contrastl thatl measuresl thel amountl andl locationl ofl CALCIFIEDl
coronary
arteryl plaques
-l Doesl notl measurel soft/unstablel plaquesl (CTl angiogram)
,QUESTION
Differentiatel betweenl highl andl moderate-intensityl statinsl byl drugl andl dose.
High
Answer:
-l Atorvastatinl 40-80mg
-l Rosuvastatinl 20-40mg
QUESTION
Differentiatel betweenl highl andl moderate-intensityl statinsl byl drugl andl dose.
Moderate
Answer:
-l Atorvastatinl 10-20mg
-l Rosuvastatinl 5-10mg
-l Simvastatinl 20-40mg
-l Pravastatinl 40-80mg
-l Lovastatinl 40mg
-l Fluvastatinl 40mgl BIDl orl 80mgl daily
-l Pitavastatinl 2-4mg
QUESTION
Differentiatel betweenl highl andl moderate-intensityl statinsl byl drugl andl dose.
Low
Answer:
, -l Simvastatinl 10mg
-l Pravastatinl 10-20mg
-l Lovastatinl 20mg
-l Fluvastatinl 20-40mg
-l Pitavastatinl 1mg
QUESTION
Pedil Lipids
Definel hazardsl ofl elevatedl lipidsl inl children.
Answer:
Significantl riskl forl havingl highl cholesteroll inl adulthoodl andl subsequentl healthl risks
QUESTION
Pedil Lipids
Applyl universall guidelinesl forl screeningl forl lipidl abnormality.
Answer:
Alll childrenl agesl 9-11yrsl
Againl atl 17-21yrs
QUESTION
Pedil Lipids
Answer:
(NEWl 2026l Update)l –l Familyl IIIl (FNPl
3)l Guidel |l Questionsl &l Answersl |l Gradel
A|l 100%l Correctl (Verifiedl Solutions)-l
UTA
QUESTION
Describel thel possiblel usel ofl coronaryl arteryl calciuml (CAC)l scoringl inl 2018l guidelines.
Answer:
Usefull when:
-l Patientl isl reluctantl tol takel al statin
-l Patientl isl hesitantl tol restartl statinl therapy
-l Menl 55-80,l Womenl 60-80l withl lowl riskl factorsl andl questionl thel benefitsl of
statinl therapy
-l Adultsl 40-55yrsl withl al 10yrl ASCVDl Calculatedl Riskl ofl 5-7.5%l thatl alsol havel risk
enhancers
-l Strongl relationl betweenl CACl Scorel andl riskl ofl MI
QUESTION
Whatl isl al CACl CT?
Answer:
-l Itl isl al CTl withl contrastl thatl measuresl thel amountl andl locationl ofl CALCIFIEDl
coronary
arteryl plaques
-l Doesl notl measurel soft/unstablel plaquesl (CTl angiogram)
,QUESTION
Differentiatel betweenl highl andl moderate-intensityl statinsl byl drugl andl dose.
High
Answer:
-l Atorvastatinl 40-80mg
-l Rosuvastatinl 20-40mg
QUESTION
Differentiatel betweenl highl andl moderate-intensityl statinsl byl drugl andl dose.
Moderate
Answer:
-l Atorvastatinl 10-20mg
-l Rosuvastatinl 5-10mg
-l Simvastatinl 20-40mg
-l Pravastatinl 40-80mg
-l Lovastatinl 40mg
-l Fluvastatinl 40mgl BIDl orl 80mgl daily
-l Pitavastatinl 2-4mg
QUESTION
Differentiatel betweenl highl andl moderate-intensityl statinsl byl drugl andl dose.
Low
Answer:
, -l Simvastatinl 10mg
-l Pravastatinl 10-20mg
-l Lovastatinl 20mg
-l Fluvastatinl 20-40mg
-l Pitavastatinl 1mg
QUESTION
Pedil Lipids
Definel hazardsl ofl elevatedl lipidsl inl children.
Answer:
Significantl riskl forl havingl highl cholesteroll inl adulthoodl andl subsequentl healthl risks
QUESTION
Pedil Lipids
Applyl universall guidelinesl forl screeningl forl lipidl abnormality.
Answer:
Alll childrenl agesl 9-11yrsl
Againl atl 17-21yrs
QUESTION
Pedil Lipids
Answer:
